Genomics has come a long way since the first human genome was sequenced in 2003. Today, sequencing a genome is not only faster but also significantly more affor...
Continue reading
In the latest episode of The Genetics Podcast, Sano CEO Patrick Short had the pleasure of speaking with Almut Heinken, a junior professor at the INSERM Institut...
Continue reading
In this webinar, "Alpha-1 Antitrypsin Deficiency: Engagement, screening, and retention," Sano Senior Project Manager, Hayley Holt, shares a case study on our wo...
Continue reading
The Genetics Podcast recap: Championing diversity and accessibility in genomics with Mavis Machirori
In the latest episode of the Genetics Podcast, Sano CEO Patrick Short had the pleasure of speaking with Mavis Machirori, a senior researcher at the Ada Lovelace...
Continue reading
Developing treatments for rare diseases involves unique obstacles due to the rarity and complexity of these conditions. To address these challenges, the FDA off...
Continue reading
In honour of Clinical Trials Day, we're sharing some reflections from our team at Sano about why we do what we do. Clinical Trials Day marks the anniversary of ...
Continue reading
A natural history study is a preplanned observational study designed to track the course of a disease over time. Its purpose is to identify demographic, genetic...
Continue reading
Natural history studies are vital for understanding disease progression, particularly in rare diseases. They provide a baseline to evaluate the effectiveness of...
Continue reading
Precision medicine takes into account individual differences in patients' genes, environments, and lifestyles to guide treatment and prevention. That reliance o...
Continue reading
Last week, our team had the opportunity to attend the World Orphan Drug Congress in Boston. The event was a dynamic gathering, where leaders from biopharma, reg...
Continue reading